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Abstract
Background: Heme is an essential molecule and plays vital roles in many biological processes. The structural
determination of a large number of heme proteins has made it possible to study the detailed chemical and
structural properties of heme binding environment. Knowledge of these characteristics can provide valuable
guidelines in the design of novel heme proteins and help us predict unknown heme binding proteins.
Results: In this paper, we constructed a non-redundant dataset of 125 heme-binding protein chains and found
that these heme proteins encompass at least 31 different structural folds with all-a class as the dominating
scaffold. Heme binding pockets are enriched in aromatic and non-polar amino acids with fewer charged residues.
The differences between apo and holo forms of heme proteins in terms of the structure and the binding pockets
have been investigated. In most cases the proteins undergo small conformational changes upon heme binding.
We also examined the CP (cysteine-proline) heme regulatory motifs and demonstrated that the conserved
dipeptide has structural implications in protein-heme interactions.
Conclusions: Our analysis revealed that heme binding pockets show special features and that most of the heme
proteins undergo small conformational changes after heme binding, suggesting the apo structures can be used for
structure-based heme protein prediction and as scaffolds for future heme protein design.
Background
This year marks the 50
th anniversary of the publication
of the very first two protein structures, myoglobin and
hemoglobin, two prototype heme proteins involved in
oxygen storage and transport [1,2]. Heme proteins, or
hemoproteins, are a group of proteins carrying heme as
the prosthetic group. Heme proteins are ubiquitous in
biological systems and exhibit diverse biological activ-
ities. These include the classical functions of diatomic
gas transportation/storage and electron transfer as
exemplified by myoglobin, hemoglobin and cytochrome
c [3,4]. More recent studies continue to reveal more
pleiotropic roles of heme proteins in transcriptional reg-
ulation [5,6], ion channel chemosensing [7], circadian
clock control [8], and microRNA processing [9].
The identification of human Rev-erb nuclear receptors
as heme sensing transcription factors represents an
important addition to the heme protein family [10,11].
Rev-erba (NR1D1) and Rev-erbb (NR1D2) have been
implicated in the regulation of circadian rhythms, lipid
and glucose metabolism, and diseases [12-15]. They
were previously categorized as orphan receptors with no
known physiological ligand. Computational modeling
and X-ray crystallization of the ligand binding domain
(LBD) of Rev-erbs provided incentives for proposing
heme as the bona fide ligand. However, the proposal
was largely based on the homology between Rev-erb
LBD and that of a known heme sensing protein E75, a
Drosophila nuclear receptor; and the authenticity of
heme as a ligand remained elusive at the time due to
t h el a c ko fu n i f i e di n f o r m a t i o no nh e m eb i n d i n gs i t e s
and heme-protein interaction. Therefore detailed analy-
sis and prediction were not possible. Yet the Rev-erb
story prompted us to ask: can we predict heme proteins?
The worldwide structural genomics projects have pro-
duced a large number of new structures with unknown
functions or annotated as hypothetical proteins [16,17].
Owing to the ubiquitous and essential nature of heme
in life, we hypothesize that some “orphan” structures in
Protein Data Bank (PDB) [18] are heme proteins.
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Rational design of heme proteins represents another
attractive research front for its potential in the develop-
ment of advanced biocatalysts and therapeutics [19-25].
Regardless of the purposes, a thorough understanding of
protein-ligand interaction is essential. The interactions
between heme and its host proteins are complicated.
Heme as a prosthetic group can exist in different forms.
Among the known forms, heme b and heme c represent
the most common types of heme groups associated with
proteins [26]. Heme b b i n d st op r o t e i n sn o n c o v a l e n t l y
while heme c forms covalent bonds between the heme
vinyl groups and two cysteine residues of proteins
(Figure 1). Previous studies suggested that the functional
versatility of heme proteins is delivered not only by the
variability of the heme molecules but also the diverse
micro-environment of the proteins, the nature of the
axial ligands to iron, and the relative solvent accessibility
of heme [27,28]. Heme proteins encompass diverse pro-
tein fold structures, among which is the well-known glo-
bin fold. However as probably the result of convergent
evolution, analogous fold structures do not always war-
rant successful functional inference. For example, the
N-terminal domain of RsbR, a protein involved in envir-
onmental stress signaling, assumes a globin-fold struc-
ture but does not bind to heme [29], highlighting the
complexity of heme proteins and the need for detailed
analysis of the heme binding surroundings.
As a first step towards a long term goal to develop
methodologies for predicting and designing novel heme
proteins, a field of interest with great potential in medi-
cine and green energy [27,30], we set out to investigate
the common characteristics of heme binding sites and
the conformational differences between apo (without
heme) and holo heme proteins, aiming at consolidating
and synthesizing a large body of experimental data and
extracting useful information and novel integrative
insights.
We take into consideration two key questions crucial
to the structure-function paradigm of heme proteins.
The first concerns the structural implications of the
heme-interactive sequence motifs. CXXCH represents
t h ec l a s s i ct y p e - c heme binding motif in which the two
vinyl groups of heme form covalent bonds with two
cysteine residues in proteins [27,28]. Recently, a heme
regulatory motif CP (for cysteine-proline dipeptide) has
received increasing attention [31-35]. But up to the pre-
sent the functional importance of this CP heme sensing
or regulatory motif has been studied only through
mutational experiments on a limited number of pro-
teins. It is still not clear from a structural point of view
how the CP motif is involved in regulation of heme
binding as has been established for the CXXCH heme c
motif.
The second question concerns the structural environ-
ment or the physiochemical features of the heme bind-
ing pockets. Of particular importance is the
conformational difference between the apo and holo
forms of heme proteins since, in most cases, only apo
structures will be available for prediction. Even though
the global and local conformational changes induced by
ligand binding in general have been surveyed by a num-
ber of studies [36-39], such systematic studies on heme
proteins have not been reported. In this study, we com-
piled a non-redundant dataset of apo-holo pairs to
examine the conformational and pocket changes in
heme proteins after heme binding.
The diversity and conservation of interactions
between heme and proteins have been analyzed pre-
v i o u s l yb yS c h n e i d e ret al.[ 2 7 ] .H o w e v e rt h e yu s e da
redundant dataset with 68 type-b heme proteins (based
o n6 0 %s e q u e n c ei d e n t i t yc u t o f f )d u el a r g e l yt ot h e
limited availability of heme protein structures [27,40].
A very recent study performed analysis on a smaller
dataset of 34 heme proteins, each of which represents
one CATH homologous family or a SCOP family [41].
There are seven different heme groups in the 34 heme
proteins with heme b and heme c as the dominant
forms [41]. Here we performed structural analysis on a
larger, non-redundant dataset of heme proteins con-
taining heme b and/or c types. Heme proteins are
found in at least 31 different structural folds in all the
four major classes based on SCOP classifications [42],
attesting to the diversity and complexity of heme-
protein interactions. The heme binding pockets are
enriched in aromatic amino acids and relatively
depleted with respect to the charged residues, glutamic
acid, aspartic acid, and lysine. We also found that the
CP motif has structural implications in heme-protein
interactions.
Figure 1 Chemical structures of heme b and heme c.
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Datasets
Two non-redundant datasets were generated in this
study. The first dataset, containing 125 heme-binding
protein chains, was used for analysis of heme binding
environment. This set was culled from protein struc-
tures in the Protein Data Bank (PDB, November 24,
2009) [18] with HEM (for heme b) or HEC (for heme c)
as ligands with the following criteria: experimental
method = X-ray crystallography, maximum resolution =
3 Å, and maximum R-value = 0.3. The protein chains
that interact with heme molecules (described in next
section “Analysis of heme interacting residues”)w e r e
selected, and a non-redundant set of 125 heme-binding
protein chains was generated using PISCES [43] with a
sequence identity cutoff of 25% (Additional file 1, Table
S1). The second dataset has 5596 protein chains in
which each pair of protein chains has less than 25%
sequence identity and each structure has a resolution of
2.5 Å or better and an R-factor of 0.3 or better. This set
was used for calculating background frequencies of
amino acids, secondary structure types, and relative sol-
vent accessibility. The sequences for the protein chains
derived from the PDB “SEQRES” records may have
cloning and expression artifacts such as His-tags at the
N- or C-terminus and some of the protein chains have
missing residues [44,45]. To avoid such artifacts and
incomplete sequences, the amino acid frequencies were
calculated using the full-length protein sequences
through mapping PDB chains to Uniprot entries with
PDBSWS [46].
Analysis of heme interacting residues
A residue is considered as a heme axial ligand if the
distance between the nitrogen, sulfur or oxygen of the
r e s i d u ea n dt h eh e m ei r o ni sw i t h i n3Å .R e s i d u e sh a v -
ing heavy atoms within 4.5 Å of any non-hydrogen
atoms of the heme molecule are identified as heme
interacting amino acids. A protein chain is considered
as heme binding if it has residue(s) as axial ligand(s) to
the heme iron or has at least ten residue interactions
with the heme molecule. DSSP was used to assign each
residue to one of three secondary structure states,
helix, strand, and coil [47]. Following the widely used
convention, H (a-helix), G (310-helix) and I (π-helix)
from DSSP are classified as helix type while E
(extended strand) and B (residue in isolated-bridge)
states are classified as strand type. All the other states
from DSSP are considered as coils. The relative solvent
accessibility was calculated by dividing the absolute
value of exposed area from DSSP over the maximum
accessibility of each residue [48]. We employ a three-
state classification for relative solvent accessibility:
buried (≤7%), intermediate (>7% and ≤37%), and
exposed (>37%), as described previously [49].
Structural comparisons between apo and holo heme
proteins
To maximize the number of possible apo-holo heme pro-
tein pairs, each of the heme protein chains was first com-
pared with all the non-heme protein chains derived from
PISCES pdbaaent file using BLAST [50]. There are a
number of ligands that are similar to heme b or c in PDB,
so structures with these heme-like ligands are not consid-
ered as apo proteins for our apo-holo comparisons. Based
on HIC-Up keyword search using heme and porphyrin
[51] and SuperLigands ligand structure similarity search
[52], we identified 55 heme-like ligands in PDB (Addi-
tional file 1, Table S2). The highly similar apo-holo heme
protein pairs (cutoffs set at 90% sequence identity and
95% sequence alignment overlap) were then culled to
generate a list of 15 non-redundant apo-holo pairs using
P I S C E Sw i t has e q u e n c ei d e n t i t yc u t o f fo f2 5 %[ 4 3 ] .F i v e
of the 15 apo proteins that contain other non-heme
ligands in the heme-binding pockets were removed from
the list as they are not truly “apo” forms with respect to
the heme binding sites. The structural differences were
evaluated with two structure alignment programs, FAST
[53] and CE [54] for structure comparisons. The similar-
ity/difference between two structures is measured by the
RMSD (root mean square deviation) of the Ca atoms of
aligned residues. The pocket/cavity was predicted using
the CASTp server (Computed Atlas of Surface Topogra-
phy of proteins)[55]. To compare the shape of the pock-
e t s ,R v s ,t h er a t i ob e t w e e nt h ev o l u m ea n dt h es u r f a c e
area is used[56].
Results and Discussion
Non-redundant dataset of heme binding proteins
There are 1998 and 113 PDB entries containing ligand
HEM (heme type-b) and HEC (heme type-c) respectively
w i t hr e s o l u t i o n so f3 Åo rb e t t e ra so fN o v e m b e r2 4 ,
2009 [18]. Among these entries, 10 (1BE3, 1BGY, 1FGJ,
1GWS, 1PP9, 1PPJ, 1S56, 1S61, 2A06, and 3H1J) con-
tain both heme type b and c. In toto 4272 protein chains
were identified as heme interacting protein chains as
described in Methods. A non-redundant dataset of 125
protein chains (114 heme-b and 11 heme-c, Additional
file 1, Table S1) were generated using PISCES with a
sequence identity cutoff of 25%[43]. Eighty-two percent
of these protein chains contain only one heme molecule
while the number of heme molecules in the remaining
protein chains ranges from 2 to 8 (Additional file 1,
Table S1). Two examples of multi-heme protein chains,
1FS7A with 5 type b and 3F29A with 8 type c heme
molecules, are shown in (Figure 2A & 2B).
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variety of protein folds. A total of 86 protein chains
(~69% of the dataset) have SCOP annotations (based on
release 1.75 and Pre-SCOP) and belong to 31 distinct
structural folds in all four major classes (Table 1) [42].
The dataset is dominated by proteins in the all-a class,
making up 64% (55 of 86) of the total. The top 4 folds,
Globin-like (a.1), Cytochrome P450 (a.104), Cytochrome
c (a.3), and Multi-heme cytochromes (a.138) represent
the well-known heme binding proteins that have been
investigated extensively (Table 1).
Structural environment of the heme binding pockets
To investigate the structural environment of heme bind-
ing pockets, we identified both residues that make coor-
dinate bonds with the heme iron and the ones that
interact with the heme porphyrin structure (Figure 2C
and Methods). Out of the 125 heme binding protein
chains, only 2PBJA and 3HCNA do not have residues
identified as axial ligands to heme iron though both
have extensive interactions with heme; instead other
small molecules, such as glutathione (GSH) in 2PBJA
(microsomal prostaglandin E synthase)[57] and imida-
zole (IMD) in 3HCNA (human ferrochelatase) [58] form
coordinate bonds with heme iron. Five different amino
acids (H, M, C, Y, K) are found to serve as axial ligands
to the heme iron with histidine as the dominant residue
(~80%) in both heme b and heme c types (Figure 3).
Heme b utilizes more cysteine residues while heme c
has slightly more methionine residues as axial ligands. It
should be pointed out that there are only 41 residues as
heme c ligands. Therefore the percentages of non-
histidine ligands may have a relatively large change with
a slight increase or decrease of ligand numbers due to
the small dataset.
The conserved interactions between protein residues
a n dh e m ew e r ep r e v i o u s l ys t u d i e db yc a l c u l a t i n ge i t h e r
the frequencies of residues that are in van der Waals
contact with heme for each fold class of b-type heme
proteins [27] or by calculating the mean number per
binding site [41]. Smith et al also applied normalized
amino acid profiles to assess the composition and con-
servation of heme binding sites [41]. Here we explored
the residue preferences in the heme binding pockets
through calculating the relative frequencies of heme
binding residues in our non-redundant dataset. The
relative frequency of each amino acid is normalized to
its background frequency.
Normally, the background frequencies used for compari-
sons are calculated from a non-redundant protein dataset.
Figure 2 Examples of three-dimensional structure of multi-heme proteins and identification of heme-binding environment.( A )
Cytochrome c nitrite reductase of Wolinella succinogenes (PDB chain: 1FS7A) with 5 heme b molecules; (B) Thioalkalivibrio nitratireducens
cytochrome c nitrite reductase (PDB chain: 3F29A) with 8 heme c molecules; (C) globin domain of globin-coupled sensor in Geobacter
sulfurreducens (PDB chain: 2W31A). The red sticks are axial ligands of the heme iron and the blue sticks represent other heme interacting
residues. For better visualization, the neighboring heme residues in A and B are colored yellow and green respectively. The heme molecules are
shown as spacefill. The images were generated using Pymol http://www.pymol.org.
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not clear whether the residue distribution in heme pro-
teins is different from that in other proteins. Therefore we
first compared the residue distributions between non-
redundant heme proteins and non-redundant all proteins.
To avoid issues with missing residues and cloning artifacts
(His-tags etc.) associated with PDB sequences, we used
native full-length protein sequences to calculate residue
compositions by mapping the PDB chains to Uniprot
entries with PDBSWS [46]. The relative residue frequen-
cies between heme proteins and all proteins show that
heme proteins tend to contain more alanine, phenylala-
nine, histidine, methionine, and tryptophan residues and
fewer cysteine, aspartic acid, isoleucine, lysine, asparagine,
and serine residues (Additional file 2, Figure S1). Statistical
analysis (c
2) revealed a significant difference between these
two frequency profiles (data not shown). In order to have a
meaningful description of the enrichment or deficiency of
Table 1 SCOP fold classes of the 125 heme binding protein chains in the non-redundant dataset
SCOP Fold # of Chains SCOP Fold Name
a.104 9 Cytochrome P450
a.1 14 Globin-like
a.123 1 Nuclear receptor ligand-binding domain
a.126 1 Serum albumin-like
a.132 2 Heme oxygenase-like
a.138 8 Multiheme cytochromes
a.24 2 Four-helical up-and-down bundle
a.266 2 Indolic compounds 2,3-dioxygenase-like
a.3 9 Cytochrome c
a.39 1 EF Hand-like
a.45 1 GST C-terminal domain-like
a.93 5 Heme-dependent peroxidases
b.1 4 Immunoglobulin-like beta-sandwich
b.2 1 Common fold of diphtheria toxin/transcription factors...
b.60 2 Lipocalins
b.66 1 4-bladed beta-propeller
b.82 1 Double-stranded beta-helix
c.150 1 EreA/ChaN-like
c.47 1 Thioredoxin fold
c.79 1 Tryptophan synthase b subunit-like PLP-dependent enzymes
c.92 1 Chelatase-like
d.110 1 Profilin-like
d.120 1 Cytochrome b5-like heme/steroid binding domain
d.151 1 DNase I-like
d.174 1 Nitric oxide (NO) synthase oxygenase domain
d.278 2 Ligand-binding domain in NO signalling & Golgi transport
d.58 3 Ferredoxin-like
e.5 2 Heme-dependent catalase-like
e.62 1 Heme iron utilization protein-like
f.21 5 Heme-binding four-helical bundle
f.24 1 Cytochrome c oxidase subunit I-like
Total: 31 86
Figure 3 Distribution of the axial ligands for heme b (HEM)
and heme c (HEC).
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background frequencies from the non-redundant set of
heme proteins as references.
The top five residues with high relative frequencies are
cysteine (C), histidine (H), phenylalanine (F), methionine
(M), and tyrosine (Y) (Figure 4A). Because four of the
top five (C, H, M, and Y) can serve as axial ligands to
heme iron (Figure 3), we removed axial ligands from the
dataset and recalculated the relative frequencies. Figure
4B shows that the level of histidine decreases to the
background level, suggesting the enrichment of histidine
is essentially due to the large number of heme histidine
ligands. The other four residues, on the other hand,
have almost the same relative frequencies with or with-
out ligand residues (Figure 4B). In heme c proteins, the
occurrence of cysteine residues is extremely high with
an eight fold enrichment compared to the background
d i s t r i b u t i o n .T h i si sn o tsurprising as the classic
CXXCH binding motif, in which the histidine serve as
ligand and the cysteine residues form covalent thioether
bonds with the heme vinyl groups, has dominant pre-
sence in heme c proteins[28].
Consistent with earlier reports, the aromatic residues
(phenylalanine, tyrosine, and tryptophan) play important
roles in protein-heme interactions through stacking
interactions with the porphyrin[27,41]. One exception is
tryptophan in heme c proteins, which showed a similar
level of occurrences compared to the background (Fig-
ure 4A). Leucine, isoleucine, and valine, which make
hydrophobic interactions with the heme ring structure,
are slightly increased over the background frequencies.
The residues with the fewest occurrences, aspartic acid,
glutamic acid, and lysine are charged residues, suggest-
ing the heme binding pocketi sm a i n l yah y d r o p h o b i c
environment. In contrast, arginine, a positively charged
residue that has been considered a major player in
anchoring the heme propionates, has a much higher
occurrence than other charged amino acids and shows a
similar (HEM) or slightly higher (HEC) level of fre-
quency to the background (Figure 4A) [27].
Figure 4 Relative frequency of the heme interacting amino acids. (A) Relative frequency of residues in heme b (HEM), heme c (HEC), and
heme b and c (ALL); (B) the relative frequency of the 5 residues with or without them as axial heme ligands.
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residues are shown in Figure 5. There are more helical
and less coil types in proteins with heme b no matter
what dataset (heme proteins or all proteins) is used as a
reference. Therefore the difference is not due to the
large number of all-a proteins in the dataset. As for
heme interacting residues in heme c, they have similar
distribution to the background (Figure 5). Based on our
3-category classification of relative solvent accessibility
[49], the heme interacting residues are less likely to be
exposed. The buried residues are comparable to the
background distribution. About 20% increase is observed
in the intermediate category (Additional file 2, Figure
S2).
Heme binding sequence motifs
To investigate possible sequence motifs involved in
heme binding, the flanking sequences with four residues
on each side of heme axial ligands were collected and
aligned. The non-redundant dataset has 34 heme c
ligands, 32 of which have histidine as axial ligands. The
alignment of these sequences shows the classic CXXCH
heme c binding motif [4,28] (Figure 6A).
Another motif worthy of note, GX[HR]XC[PLAV]G,
comes from the heme b proteins with cysteine as axial
ligands (Figure 6B). The motif represents the classic
CYP signature heme binding motif FXXGXXCXG in
bacteria, plant, and mammalian cytochrome P450 s
[59-61]. At the -4 and +2 positions (with ligand cysteine
as reference position) are small amino acids (glycine)
while the -2 position prefers a positively charged amino
acid such as histidine or arginine. These positively
charged residues interact electronically with the nega-
tively charged heme propionates (Figure 6C and 6D).
The small glycine residue at the -4 position may provide
the flexibility needed for positioning the positively
charged residues close to heme propionate groups. The
+1 position is dominated by proline and hydrophobic
amino acids, leucine, alanine, valine and isoleucine. Six
of the eighteen cases have proline right after the axial
ligand cysteine, reminiscent of the dipeptide CP motif
being implicated in heme sensing and regulation
[31-35,62]. While the importance of CP motif has been
studied through deletion or site-directed mutation
experiments in several important proteins, including
transcription repressor Bach1[63], iron regulatory pro-
tein 2 (IRP2) [31], circadian factor period 2 (Per2) [34]
and δ-aminolevulinic acid synthase (ALAS) [33], the
possible role of the CP motif in heme interaction from a
structural point of view remains unclear as the struc-
tures for most of these proteins with such CP motifs are
unknown.
All the six CP dipeptides that have direct physical
interactions with heme exhibit similar structural roles
with the cysteines serving as ligands to the heme iron
and the proline residue introducing a bend for the
downstream structures, mainly a-helices, to steer them
a w a yf r o mt h eh e m ef a c e( F i g u r e7 Ba n d7 C ) .A
seventh protein chain, 2PBJA, contains a CP where the
proline shows highly similar structural implication,
whereas the cysteine residue interacts with heme but
not as a ligand. Instead, the presence of a glutathione
molecule (GSH), which forms a coordination bond
with the heme iron, seems to push the cysteine slightly
away from the axial ligand position (5.25 Å from heme
iron) [57]. Considering the conformation in the pro-
line-bend structure and the small distance between
cysteine and heme iron, it is likely that the cysteine
could serve as a heme ligand if GSH is not present in
the structure. Interestingly, a closer examination of the
structural conformation downstream of the proline
residue in 2CIWA (cloroperoxidase), 3CQVA (Rev-
erb), and 2PBJA (microsomal prostaglandin E
synthase), which have the CP heme motifs with con-
served proline, indicates nearly perpendicular orienta-
tion to the heme plane (Figure 7A, 7B and 7D). In
contrast, in the P450 family where the proline residue
is less conserved, with leucine, isoleucine, and methio-
nine also found at the position of proline as shown in
the motif logo (Figure 6B), the a-helices following the
proline residue are in parallel with the heme plane
(Figure 7C). The difference suggests a different struc-
tural role for the proline in conserved CP dipeptides
from that in the less-conserved CP dipeptides, more
specifically at the proline position.
CP dipeptides have also been implicated in indirect
interaction with heme. Ragsdale and colleagues reported
a novel role for CP motifs in heme oxygenase 2
(HMOX-2) as a thiol/disulfide redox switch that loca-
lizes outside the heme-binding pocket [62,64,65], there-
fore regulating heme-protein interaction via sensing
redox status in the environment. There are a total of
twenty-nine CP dipeptides in our dataset. Less than a
Figure 5 Frequencies of secondary structure types for heme
interacting residues.
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Page 7 of 13quarter of them (in 7 protein chains including 2PBJA)
show physical interactions with heme molecules. It
would be impractical at this point to predict the func-
tional role of the remaining CP dipeptides in heme-pro-
tein interaction, mainly due to the limited sample size
and the lack of structural details on heme pocket-CP
interaction. Here we made use of statistical analysis to
indirectly assess the functional relevance of CP dipep-
tides in heme interaction. The rationale behind the
assay is that, if CP dipeptides are important heme signa-
tures for heme interaction, the expected occurrences of
CP dipeptides in hemoproteins should be higher com-
pared to control population. We found no statistically
significant difference between the presence of CP dipep-
tides in heme proteins and non-heme proteins (data not
shown), suggesting other yet to be identified factors may
exist to help determine the role CP dipeptides play in
heme binding [31]. It should be noted that we do not
exclude the possibility that in the control sample there
exist unknown hemoproteins;h o w e v e rf o rt h e mt os i g -
nificantly affect the frequency of CP signals there would
have to be a considerably large fraction of the control
proteins being analyzed to be heme-interacting, which
we anticipate as less likely.
Structure comparison between apo and holo heme
proteins
An interesting question related to structure-based heme
binding protein design and prediction is the degree of
global conformational transition and the local changes
of the heme-binding pocket upon heme binding. We
collected 446 heme protein chains (after removing heme
protein chains with at least 90% sequence identity) and
compared their sequences with the protein chains with-
out heme or heme-like ligands (Additional file 1, Table
S2). One hundred seventy-nine heme protein chains are
found to have apo structures with high sequence simi-
larity and coverage. After removing redundant apo/holo
pairs with a 25% sequence identity cutoff and proteins
with non-heme or non-heme-like ligands occupying the
heme binding pocket, the final dataset consists of 10
apo-holo protein pairs. Table 2 shows that 9 out of 10
proteins undergo very small global conformational
changes after heme binding with RMSDs of 1.03Å or
less. For example the 2ZDOA-1XBWD pair (iron-regu-
lated surface determinant IsdG from Staphylococcus
aureus) has an RMSD of 0.59 Å. In the absence of
heme, the protein assumes the same conformation as
the holo protein with heme (Figure 8A, B). Even the
Figure 6 Sequence motifs surrounding the axial ligands. (A) Sequence logo from 32 heme c proteins with histidine as axial ligand shows
the classic CXXCH heme c binding motif; (B) Sequence logo from 18 heme b proteins with cysteine as axial ligand. The sequence logos were
created with WebLogo [74]; (C) Arginine-334 (red sticks) of 1N97A interacts with heme propionates (red spheres); and (D) Interactions between
histidine-353 (red sticks) of 1GWIA and heme propionate groups (red spheres).
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The one with relatively large conformational changes is
Rev-erb (3CQVA-2V7CA). Without heme the C-term-
inal helix (residues 568-576) moves towards the heme
pocket with His568 (heme-binding ligand) facing away
from the binding pocket (Figure 8C, D) [66].
Three of the ten heme proteins in Table 2 have multi-
ple known apo structures. 1KBIA (flavin-binding domain
of Baker’s yeast flavocytochrome b2), 1N45A (human
heme oxygenase-1), and 1N5UA (human serum albu-
min) have 9, 3, and 28 apo structures respectively (with
at least 99% sequence identity, Additional file 1, Table
S3). Because proteins are inherently dynamic and con-
formational selection has been considered as a major
mechanism for biomolecular recognition [67-69], we
checked the conformational differences between each of
the apo structures and the holo structures. Figure 9A
shows the RMSD (Ca atoms of aligned residues) values
of the apo-holo structural differences. The RMSDs are
g e n e r a l l yl e s st h a n1 Åf o r1 K B I Aa n d1 N 4 5 A .O nt h e
contrary, apo structures of 1N5UA form two clusters.
Members of one cluster with 12 apo structures have
RMSDs around 0.8Å while the other contains 15 apo
structures with RMSDs ranging from 4 to 5Å. Through
manual inspection, we found that the differences are
caused by the numbers of non-heme ligands in struc-
tures. In addition to heme, 1N5UA also has 5 myristic
acid (MYR) molecules (Figure 9B). The apo structures
with higher RMSDs either do not have ligands (Figure
9 C )o rh a v eo n l yo n eo rt w on o n - M Y Rl i g a n d s .F o r
example, 1E7AA and 2BX8B have 2 PFL and 1 AZQ
respectively. On the other hand, apo structures with
Figure 7 Three-dimensional structures of heme proteins with “CP” motifs. (A) 3CQVA; (B) 2CIWA; (C) 1GIWA; and (D) 2PBJA. The CP
dipeptides are shown as red sticks. The immediate downstream structures of the CP dipeptides are shown in blue.
Table 2 Comparisons between apo and holo heme protein structures
holo-chain volume
(Å
3)
surface
area (Å
2)
Rvs
a apo-chain volume
(Å
3)
surface area (Å
2) Rvs
a sequence identity% RMSD
(Å)
1KBIA 458.1 432 1.060 1SZFB 1039.3 708.3 1.468 99 0.40
1N45A 1634.7 1139.3 1.435 1S8CD 845.1 634.4 1.332 100 0.86
1N5UA ** * 3CX9A * * * 100 0.60
2ITFA 721.7 521 1.385 2ITEB 803.4 551 1.457 100 0.60
2NWBA ** * 1ZEEB * * * 96 0.75
2OFRX 1211.1 857.4 1.413 2OFMX 783.3 642.7 1,219 100 1.03
2R7AA 1362.6 963.4 1.414 2RG7D 1558.1 1019.6 1.528 100 0.91
2ZDOA 808.7 553.9 1.460 1XBWD 766.9 544.2 1.409 99 0.59
3CQVA 1638.3 1099 1.490 2V7CA 537.1 436.2 1.232 94 2.32
3EMMA 399 383.1 1.042 2A13A 910.8 635.2 1.434 100 0.53
aRvs: ratio between volume and surface area.
*Data not shown because CASTp predicts a very large cavity, covering several pockets.
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generally have smaller RMSDs (Figure 9D). Therefore,
under similar environment, there are relatively small
structural differences between holo and apo heme pro-
tein structures.
It should be noted that the above comparisons are
based on heme proteins that have stable apo structures
solved through X-ray crystallography. For some proteins,
as in the case of hemoglobin, the absence of ligand(s)
can increase the flexibility and cause partial unfolding of
the protein structure, making it difficult for structure
determination [70,71]. Furthermore, intrinsically disor-
dered or unstructured regions are considered to be
responsible for many important cellular functions such
as ligand binding [72,73]. However the existence of such
flexible apo structures would not interfere with our goal
in structure-based heme protein prediction as we aim to
take the existing apo structures in PDB as inputs [18].
Other features useful for comparing apo-holo heme
proteins are the pocket size and shape. Due to different
heme binding modes (partially exposed or fully
embedded, Additional file 2 Figure S3) and the difficulty
in identifying the exact heme binding pocket from exist-
ing automatic programs, the sizes of heme binding pock-
ets vary from small (~400 Å
3) to very large (over 2000
Å
3) (Table 2). In addition, the changes in absolute pocket
volumes after heme binding are variable. Small changes
Figure 8 Structural comparison of apo-holo heme protein
pairs. (A,B) 2ZDOA-1XBWD; (C,D) 3CQVA-2V7CA.
Figure 9 Examples of heme proteins with multiple apo structures. (A) RMSD distribution of apo structure of three heme protein chains,
1KBIA, 1N45A, and 1N5UA. The 28 apo structures of 1N5UA form two clusters (red ovals). (B) Structure of 1N5UA with one heme and five
myristic acid molecules (MYR, red spacefill). (C) Structure of 1AO6A with no ligands. (D) Structure of 3CX9A with five myristic acid molecules
(MYR, red spacefill) and one LPX ligand (orange spacefill).
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Page 10 of 13are seen in 2ITFA-2ITEB, 2R7AA-2RG7 D, and 2ZDOA-
1XBWD. Other pairs exhibited significant changes in
volume despite the minimal conformational change
(Table 2). To take the shape into consideration we calcu-
lated the Rvs value (the ratio of pocket volume over the
pocket surface area) of each pocket. Most of the apo or
holo proteins have Rvs values around 1.4. To further
investigate whether the binding pocket can be used as
one of the characteristics for heme protein prediction, we
compared the Rvs distributions between heme binding
pockets and pockets in non-heme proteins (proteins that
don’t have heme ligand(s) and are not homologous to
heme proteins) with similar sizes ranging from 350 to
2000Å
3. The Rvs of heme binding pockets has a narrow
distribution whereas the Rvs from similar pocket sizes of
non-heme proteins has a wide spread with a long right
tail (Additional file 2, Figure S4-A). We also investigated
the distribution of Rvs normalized to a sphere shape as
introduced by Sonavane and Chakrabarti [56]. A similar
trend was found (Additional file 2, Figure S4-B). It should
be pointed out that, even though unknown heme pro-
teins may be included in the non-heme dataset, many
non-heme proteins share similar pocket characteristics.
Conclusion
In this study, we surveyed the known heme protein
structures for the purpose of structure-based heme pro-
tein prediction and novel heme protein design. We first
compiled a non-redundant dataset of 125 heme (type b
and c) binding protein chains that encompass a large
number of protein structural folds, reflecting the diversi-
fied roles of heme proteins. Structural analysis revealed
that the residues interacting with heme are mainly non-
polar, especially aromatic amino acids, providing a
hydrophobic environment for the heme ring structure.
We also investigated the possible structural roles of CP
motifs that are implicated in the regulation of heme
binding and have received much attention recently.
While the CP dipeptide is not as strong a signature for
heme binding as the classic CXXCH heme c binding
motif, the proline in the heme-interacting CP dipeptides
assume important structural roles when CP is conserved
and the cysteine functions as an axial ligand with heme
iron. Indirect interaction between CP motifs and heme
binding has also been reported in HMOX-2 protein, in
which CP dipeptides form thiol/disulfide redox switch
away from the heme binding pocket [62,64], suggesting
the heterogeneity of CP-heme interactions.
Comparisons between the apo and holo heme proteins
indicate that most of the heme proteins undergo small
conformational changes after heme binding, suggesting
the apo structure can be used for structure-based heme
protein prediction and as a scaffold for heme protein
design. In addition our analysis on the heme binding pock-
ets showed that despite the different sizes, the Rvs values
of heme binding pockets are confined in a small range,
whereas the data from non-heme binding proteins spread
over a large range. We will apply the results from this
study to investigate if any of the hypothetical proteins in
PDB are potential heme proteins through computational
prediction and experimental validations in the near future.
Additional material
Additional file 1: Datasets used in structural analysis of heme
proteins. Table S1: a list of 125 non-redundant heme-binding protein
chains; Table S2: heme and heme-like ligands in PDB; Table S3: heme
proteins with multiple apo structures
Additional file 2: Comparative analysis of heme-binding proteins
and non-heme proteins in terms of amino acid frequency, relative
solvent accessibility, and Rvs (ratio between volume and area).
Figure S1: relative frequencies of amino acids in non-redundant heme
proteins; Figure S2: frequencies of relative solvent accessibility for heme
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